JP Morgan Chase
CELG

JP Morgan Chase’s Celgene Corp CELG Stock Holding History

JP Morgan Chase’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,105,500
Closed -$209M – 6130
2019
Q3 		$209M Buy
2,105,500
+225,000
+12% +$21.4M 0.04% 428
2019
Q2 		$174M Sell
1,880,500
-1,237,300
-40% -$117M 0.03% 491
2019
Q1 		$294M Buy
3,117,800
+2,125,900
+214% +$186M 0.06% 326
2018
Q4 		$63.6M Buy
991,900
+265,800
+37% +$19.6M 0.01% 805
2018
Q3 		$65M Buy
726,100
+157,100
+28% +$13.9M 0.01% 892
2018
Q2 		$45.2M Sell
569,000
-5,100
-0.9% -$423K 0.01% 1027
2018
Q1 		$51.2M Sell
574,100
-712,200
-55% -$68.4M 0.01% 924
2017
Q4 		$134M Buy
1,286,300
+539,500
+72% +$60.9M 0.03% 529
2017
Q3 		$107M Buy
746,800
+362,700
+94% +$49.4M 0.02% 603
2017
Q2 		$49.9M Sell
384,100
-193,940
-34% -$23.8M 0.01% 912
2017
Q1 		$71.9M Buy
578,040
+87,340
+18% +$10.5M 0.02% 761
2016
Q4 		$56.8M Buy
490,700
+451,602
+1,155% +$50.3M 0.01% 829
2016
Q3 		$4.09M Sell
39,098
-625,600
-94% -$67.7M ﹤0.01% 2391
2016
Q2 		$65.6M Buy
664,698
+599,698
+923% +$62M 0.02% 720
2016
Q1 		$6.51M Buy
65,000
+39,900
+159% +$4.11M ﹤0.01% 2046
2015
Q4 		$3.01M Buy
25,100
+20,000
+392% +$2.31M ﹤0.01% 2531
2015
Q3 		$552K Sell
5,100
-69,524
-93% -$8.63M ﹤0.01% 3372
2015
Q2 		$8.64M Sell
74,624
-30,800
-29% -$3.52M ﹤0.01% 2021
2015
Q1 		$12.2M Sell
105,424
-437,876
-81% -$52.3M ﹤0.01% 1773
2014
Q4 		$60.8M Buy
543,300
+7,800
+1% +$823K 0.01% 846
2014
Q3 		$50.8M Buy
+535,500
New +$48.3M 0.01% 889

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

JP Morgan Chase's CELG Position: Q4 2019 in Review

JP Morgan Chase sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,354,501 shares — an estimated $929M sold.

JP Morgan Chase first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.54B in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • JP Morgan Chase reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • JP Morgan Chase sold 9,354,501 Celgene Corp shares in Q4 2019, an estimated $929M.
  • JP Morgan Chase first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • JP Morgan Chase's Celgene Corp position peaked at $2.54B in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.